CG Oncology (CGON) Operating Margin (2023 - 2025)
Historic Operating Margin for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to 3068.97%.
- CG Oncology's Operating Margin rose 627333600.0% to 3068.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 8285.33%, marking a year-over-year increase of 57456700.0%. This contributed to the annual value of 10067.25% for FY2024, which is 171136300.0% up from last year.
- Per CG Oncology's latest filing, its Operating Margin stood at 3068.97% for Q3 2025, which was up 627333600.0% from 81161.54% recorded in Q1 2025.
- In the past 5 years, CG Oncology's Operating Margin ranged from a high of 3068.97% in Q3 2025 and a low of 1935500.0% during Q4 2023
- For the 3-year period, CG Oncology's Operating Margin averaged around 253606.61%, with its median value being 23290.99% (2024).
- Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 2000000000bps in 2024, then crashed by -769140900bps in 2025.
- Over the past 3 years, CG Oncology's Operating Margin (Quarter) stood at 1935500.0% in 2023, then skyrocketed by 100bps to 8344.08% in 2024, then skyrocketed by 63bps to 3068.97% in 2025.
- Its Operating Margin stands at 3068.97% for Q3 2025, versus 81161.54% for Q1 2025 and 8344.08% for Q4 2024.